Tudor Investment Corp’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-31,321
Closed -$232K 2425
2024
Q1
$232K Buy
+31,321
New +$260K ﹤0.01% 1971
2022
Q4
Sell
-11,646
Closed -$143K 2496
2022
Q3
$143K Buy
+11,646
New +$181K ﹤0.01% 2129
2022
Q2
Sell
-22,692
Closed -$432K 2208
2022
Q1
$432K Sell
22,692
-15,551
-41% -$289K 0.01% 1354
2021
Q4
$1.01M Buy
38,243
+27,121
+244% +$933K 0.02% 985
2021
Q3
$457K Sell
11,122
-11,144
-50% -$611K 0.01% 1718
2021
Q2
$1.26M Buy
+22,266
New +$822K 0.02% 759
2020
Q3
Sell
-128,111
Closed -$3.79M 1353
2020
Q2
$3.79M Buy
128,111
+87,927
+219% +$2.3M 0.19% 91
2020
Q1
$797K Buy
40,184
+16,831
+72% +$424K 0.07% 316
2019
Q4
$691K Buy
+23,353
New +$583K 0.03% 620
2017
Q4
Sell
-40,905
Closed -$982K 1120
2017
Q3
$982K Buy
40,905
+9,011
+28% +$172K 0.03% 401
2017
Q2
$535K Buy
31,894
+5,709
+22% +$103K 0.02% 548
2017
Q1
$584K Buy
+26,185
New +$543K 0.02% 599

Other funds holding EDIT

Tudor Investment Corp's EDIT Position: Q2 2024 in Review

Tudor Investment Corp sold out of Editas Medicine (EDIT) in Q2 2024, closing a stake of 31,321 shares — an estimated $232K sold.

Tudor Investment Corp first reported a position in EDIT in Q1 2017 and held it in 12 quarters. The position peaked at $3.79M in Q2 2020. 235 funds tracked by Wall St. Rank hold EDIT as of Q2 2024.

  • Tudor Investment Corp reported no remaining Editas Medicine position as of Q2 2024 after selling out during the quarter.
  • Tudor Investment Corp sold 31,321 Editas Medicine shares in Q2 2024, an estimated $232K.
  • Tudor Investment Corp first reported a position in Editas Medicine in Q1 2017 and held it in 12 quarters.
  • Tudor Investment Corp's Editas Medicine position peaked at $3.79M in Q2 2020.
  • 235 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2024.

Based on Tudor Investment Corp's 13F filing for Q2 2024, filed 14 Aug 2024.